Allisartan isoproxil

DB18880InvestigationalSmall molecule

Allisartan isoproxil is under investigation in clinical trial NCT03264352 (Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes).

Mechanism: Pharmacologically active on Type-1 angiotensin II receptor
Curator reviewed
Formula / weight: C₂₇H₂₉ClN₆O₅ · 553.02 g/mol (avg)

Resolves to

Compound

UNIIDI4662MK4NCAS947331-05-7

Structure

InChIKeyXMHJQQAKXRUCHI-UHFFFAOYSA-NSMILESCCCCC1=NC(Cl)=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=O)OCOC(=O)OC(C)C

Targets

P30556AGTR1

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Allisartan isoproxil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account